Men's Health

    GLP-1 Before Surgery: Do You Need to Stop Semaglutide?

    RespondWell Editorial·Published ·5 min read·GLP-1 · semaglutide · surgery and anesthesia

    Most people taking a GLP-1 medication such as semaglutide or tirzepatide do not need to stop it before surgery, according to 2024 multisociety guidance from anesthesiology, gastroenterology, and surgical societies. The decision depends on your individual risk of delayed stomach emptying, and it should be made with your surgical, anesthesia, and prescribing teams. This guide explains why GLP-1s matter before anesthesia, what current guidance recommends, and what to tell your care team before any procedure that involves sedation.

    Why Do GLP-1 Medications Matter Before Anesthesia?

    GLP-1 receptor agonists slow gastric emptying, which is one of the ways they reduce appetite and support weight loss. (For the full mechanism, see how GLP-1s work.) That same effect can mean food or liquid stays in the stomach longer than standard fasting rules assume.

    Under general anesthesia or deep sedation, the protective reflexes that normally keep stomach contents out of the airway are suppressed. If the stomach is not empty, contents can be inhaled into the lungs. This is called pulmonary aspiration, and it can cause aspiration pneumonitis or pneumonia.

    What does the FDA label say?

    In late 2024, the FDA updated prescribing information across the GLP-1 class, including semaglutide and tirzepatide, to note rare postmarketing reports of pulmonary aspiration in patients undergoing general anesthesia or deep sedation who had residual stomach contents despite following standard fasting instructions. The label states that there is not enough data to define specific fasting or drug-hold recommendations, and it advises patients to tell their healthcare providers about any planned procedure.

    Do You Need to Stop Semaglutide or Tirzepatide Before Surgery?

    Guidance has changed over the past few years, which is why patients often hear conflicting advice.

    The 2023 approach: hold the medication

    In 2023, the American Society of Anesthesiologists (ASA) issued consensus-based guidance suggesting that weekly GLP-1 injections be held for one week before elective procedures and daily formulations be held on the day of the procedure. Gastroenterology societies responded that there was limited data to support routinely stopping these drugs, and some patients experienced short-notice cancellations.

    The 2024 multisociety guidance: assess risk, most continue

    In October 2024, the ASA, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons published joint guidance. Its two core recommendations:

    • Shared decision-making. Whether to continue a GLP-1 before a procedure should be decided by the patient together with the procedural, anesthesia, and prescribing teams, weighing metabolic benefit against individual aspiration risk.
    • Minimize aspiration risk instead of reflexively stopping. Patients without elevated risk may continue their medication. For higher-risk patients, the care team can use a liquid-only diet for 24 hours before the procedure and adjust the anesthesia plan.

    The guidance also notes that stopping a GLP-1 carries its own risks, including loss of blood sugar control in patients with diabetes, and that the risk of delayed gastric emptying tends to decrease the longer a patient has been on a stable dose. The authors describe it as clinical guidance rather than a formal evidence-based guideline, and in rare cases an elective procedure may still be postponed.

    Who Is at Higher Risk of Aspiration on a GLP-1?

    The multisociety guidance identifies several factors that may raise the risk of delayed stomach emptying:

    • Dose escalation phase. Patients early in treatment or still titrating up are more likely to have slowed gastric emptying than those on a stable maintenance dose. See the semaglutide titration guide for how escalation typically works.
    • Higher doses. Higher doses are associated with more gastrointestinal side effects.
    • Active GI symptoms. Nausea, vomiting, abdominal pain, bloating, or constipation around the time of the procedure. Guidance suggests waiting until these resolve before elective surgery. Common GI effects are covered in tirzepatide side effects.
    • Other conditions that slow digestion, which your care team will review as part of a normal preoperative assessment.

    The guidance cautions that obesity alone should not drive the decision, and that all patients should be screened for symptoms of delayed gastric emptying on the day of the procedure.

    What Should You Tell Your Care Team Before a Procedure?

    Because the right approach is individualized, the most useful thing you can do is give your teams complete information early, ideally when the procedure is first scheduled rather than the morning of:

    • The specific medication (semaglutide or tirzepatide), whether it is compounded, and your current dose.
    • The day you take your weekly injection and when your last dose was.
    • Whether you recently increased your dose or are still titrating.
    • Any current nausea, vomiting, fullness, reflux, or constipation.
    • The contact for your prescribing clinician, so the surgical and anesthesia teams can coordinate.

    This applies to more than major surgery. Colonoscopies, upper endoscopies, dental procedures under deep sedation, and orthopedic procedures all involve sedation or anesthesia. Shift workers who schedule procedures around rotating days off may find it helpful to flag their GLP-1 use at the scheduling call, since a last-minute change to the plan can be harder to rearrange. Do not stop or skip doses on your own; follow the plan your care teams agree on.

    Frequently Asked Questions

    How long before surgery should I stop semaglutide?

    Under 2024 multisociety guidance, many patients do not need to stop at all. When a hold is used, older guidance suggested holding a weekly GLP-1 for one week before the procedure. Your surgical, anesthesia, and prescribing teams should make this decision together based on your risk factors.

    Does tirzepatide carry the same anesthesia warning as semaglutide?

    Yes. The FDA’s late-2024 labeling update on pulmonary aspiration during general anesthesia or deep sedation applies across the GLP-1 receptor agonist class, including both semaglutide and tirzepatide.

    What is the 24-hour liquid diet before surgery on a GLP-1?

    For patients at higher risk of delayed stomach emptying, the multisociety guidance suggests a liquid-only diet for at least 24 hours before the procedure, similar to colonoscopy prep, to reduce the chance of residual stomach contents. Your care team will give you specific instructions.

    Coordinating GLP-1 Treatment With RespondWell

    If you are on compounded semaglutide or tirzepatide through RespondWell and have a procedure coming up, contact your RespondWell provider as soon as it is scheduled so your prescribing team can coordinate with your surgeon and anesthesia team. If you are considering GLP-1 treatment, start your RespondWell consultation to review whether semaglutide or tirzepatide is a fit for you.

    RespondWell

    Healthcare that doesn't suck. Built by first responders, for first responders.

    Verify Approval for www.respondwell.healthColorado Company

    Connect

    ContactText us: (888) 893-8110

    Sign up to receive tips and offers:

    By submitting your email address you agree to receive emails from us. Privacy Policy.

    Ask AI about RespondWell

    © 2026 RespondWell, LLC. All rights reserved. RespondWell, LLC is based in Denver, Colorado, with clinicians and pharmacies licensed in all 50 states.Sitemap

    The information on this website is for general informational purposes only and has not been evaluated by the FDA. It is not a substitute for professional medical advice, diagnosis, or treatment. RespondWell connects first responders with independent licensed providers and pharmacies to improve access to culturally competent care. RespondWell does not practice medicine, prescribe medications, or operate pharmacies — all clinical services are delivered by independent clinicians. Prescriptions require a licensed provider's approval after a medical evaluation; not all patients will qualify. Based on your needs, a provider may prescribe brand-name, generic, or compounded medications. Compounded drugs are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. RespondWell does not claim any compounded product is equivalent to, or associated with, any branded or FDA-approved drug. Results vary; no guarantees are made. In a medical emergency, call 911 or go to the nearest ER. Telehealth services and prescriptions may not be available in all states. Safety Information.

    By accessing this website, you agree to our Terms of Use, Privacy Policy, Notice of Privacy Practices, Telehealth Consent, and SMS / Messaging Terms.